Table 1 The influence of ENTPD1 expression on the survival of THCA patients
Characteristics | Subtypes | HR (95%CI) | Logrank P-value |
|---|---|---|---|
Gender | female | 0.34 (0.09–1.19) | 0.076 |
male | 0.04 (0–0.31) | 7.9E-06 | |
Cancer stage | 1 | 2.41 (0.15–38.52) | 0.520 |
2 | 0.30 (0.02–4.87) | 0.370 | |
3 | 0.15 (0.03–0.76) | 8.5E-03 | |
4 | 0.08 (0.01–0.73) | 3.8E-03 | |
Mutation burden | high | 0.25 (0.06–0.95) | 0.028 |
low | 0.12 (0.01–1.20) | 0.032 | |
B-cells | enriched | 0.22 (0.02–2.10) | 0.150 |
decreased | 0.12 (0.03–0.43) | 1.0E-04 | |
Macrophages | enriched | 0.16 (0.03–0.80) | 0.011 |
decreased | 0.19 (0.04–0.93) | 0.021 | |
Natural killer T-cells | enriched | 0.39 (0.07–2.14) | 0.260 |
decreased | 0.08 (0.02–0.37) | 3.3E-05 | |
Regulatory T-cells | enriched | 0.21 (0.07–0.65) | 2.7E-03 |
decreased | 0 (0-Inf) | 0.049 |